title: Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury.
abstract: BACKGROUND
  Chemotherapy destroys primordial follicles and can lead to ovarian atrophy. Although reports indicate that apoptosis is the mechanism responsible for follicle loss, additional pathways can be involved. This study investigates the damage in human ovaries after administration of non-sterilizing doses of chemotherapy.
  
  
  METHODS
  In a blind study, pathological changes in ovarian tissue harvested for cryopreservation were evaluated. The study group comprised young non-sterile cancer patients, previously exposed to chemotherapy who were (mean +/- SD), when compared with non-exposed patients.
  
  
  RESULTS
  Thirty-five cancer patients aged 28.7 +/- 6.74; 17 were previously exposed to non-sterilizing chemotherapy and 18 were not. In all samples, primordial follicles were present. In previously exposed patients, damage to cortical blood vessel and proliferation of small vessels was observed. The cortex showed focal areas of fibrosis with disappearance of follicles (sensitivity 76%, positive predictive value 75% for <37 years old patients). Older patients, not exposed to chemotherapy (5/7) showed similar pathological changes.
  
  
  CONCLUSIONS
  Injury to blood vessels and focal ovarian cortical fibrosis are aspects of ovarian damage caused by chemotherapy. These findings indicate a potential additional mechanism of damage to the direct apoptotic effect of chemotherapy on follicles. The possibility that these changes are involved in ageing ovaries should be further investigated.
authors.affiliation: Department of Obstetrics and Gynecology, Chain Sheba Medical Center, 52621 Tel-Hashomer, Israel. meirow@post.tau.ac.il
authors.forename: D
authors.initials: D
authors.lastname: Meirow
authors.forename: J
authors.initials: J
authors.lastname: Dor
authors.forename: B
authors.initials: B
authors.lastname: Kaufman
authors.forename: A
authors.initials: A
authors.lastname: Shrim
authors.forename: J
authors.initials: J
authors.lastname: Rabinovici
authors.forename: E
authors.initials: E
authors.lastname: Schiff
authors.forename: H
authors.initials: H
authors.lastname: Raanani
authors.forename: J
authors.initials: J
authors.lastname: Levron
authors.forename: E
authors.initials: E
authors.lastname: Fridman
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001808:Blood Vessels / Q000187:drug effects / Q000473:pathology; D005260:Female; D005355:Fibrosis; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010053:Ovary / Q000098:blood supply / Q000187:drug effects / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents